SCHEMBL10072100

SCHEMBL10072100

O=C(/C=C/c1ccc(CNC2(C(=O)OC3CCCC3)CCOCC2)cn1)NO

nearest known ligand 0.38

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 17/20 0.38
HDAC3 O15379 15/20 0.38
HDAC6 Q9UBN7 15/20 0.38
HDAC1 Q13547 14/20 0.38
HDAC8 Q9BY41 14/20 0.38
HDAC5 Q9UQL6 10/20 0.37
MEF2D Q14814 4/20 0.36
HDAC7 Q8WUI4 8/20 0.36
HDAC2 Q92769 8/20 0.36
HDAC10 Q969S8 8/20 0.36
HDAC11 Q96DB2 8/20 0.36
HDAC9 Q9UKV0 8/20 0.36
CDK9 P50750 1/20 0.36
MMP1 P03956 1/20 0.32
MMP13 P45452 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL181811 0.93 HDAC4 (0.40) HDAC4HDAC3HDAC6HDAC1HDAC8
SCHEMBL181963 0.93 HDAC4 (0.40) HDAC4HDAC3HDAC6HDAC1HDAC8
SCHEMBL181962 0.93 HDAC4 (0.40) HDAC4HDAC3HDAC6HDAC1HDAC8
SCHEMBL181812 0.93 HDAC4 (0.40) HDAC4HDAC3HDAC6HDAC1HDAC8
SCHEMBL181679 0.92 HDAC3 (0.41) HDAC4HDAC3HDAC6HDAC1HDAC8
SCHEMBL181678 0.92 HDAC3 (0.41) HDAC4HDAC3HDAC6HDAC1HDAC8
SCHEMBL2704435 0.88 HDAC3 (0.50) HDAC4HDAC3HDAC6HDAC1HDAC8
SCHEMBL2704438 0.88 HDAC3 (0.50) HDAC4HDAC3HDAC6HDAC1HDAC8
SCHEMBL10072245 0.87 HDAC1 (0.34) HDAC4HDAC3HDAC6HDAC1HDAC8
Trifluoroacetic Acid SCHEMBL9894997 0.87 HDAC3 (0.38) HDAC4HDAC3HDAC6HDAC1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012025701-A1 ALPHA, ALPHA - DI SUBSTITUTED GLYCINE ESTER DERIVATIVES AND THEIR USE AS HDAC INHIBITORS CHROMA THERAPEUTICS LTD. (GB) 2012-03-01 WO disclosed